Reply to the 2 attached DB post 200 words each
Johnson & Johnson (JNJ) is a drug manufacturer in the healthcare sector based out of New Jersey. Looking at the current charts and statistics, JNJ is at an increase running at about 148.14. Looking at the year to date, prices for Johnson & Johnson has steadily increased. Revenue for Johnson & Johnson for 2017 has increased compared to 2016. The company has a gross profit of 50,205,000 compared to 2016 having a gross profit of 48,538,000. Financially, the company is stable and consistently growing and gaining revenue. O'Connell (2017) discusses the performance of the company and how it has been affecting stock prices. He states "Since Jan. 1, the quote for JNJ stock has risen from $113 to $136 per share, and is up 15.4 percent on a 52-week basis" (O'Connell, 2017). Overall the article suggests that Johnson and Johnson may be a great company to invest in for the long-haul but may want to wait for a more favorable price as the price of stock is currently quite high.
Looking into the conversations made on JNJ : Summary for Johnson & Johnson (2018), many people are wanting to invest; however, the price is so high that it is actually pushing investors away. Investing in a company like Johnson & Johnson may prove to have significant benefits as the company is economically and financially doing very well. Revenue for the company is high and continues to increase, as well as the stock for the company continues to be positive. Even looking at the natural disasters that have occurred, such as Hurricane Irma, Johnson & Johnson continues to push forward while being near the top of stocks within the drug and pharmaceutical companies.
References
JNJ : Summary for Johnson & Johnson. (2018, January 22). Retrieved January 22, 2018, from https://finance.yahoo.com/quote/JNJ/community?p=JNJ
O'Connell, B. (2017, June 23). Should I buy Johnson & Johnson stock? Retrieved January 22, 2018, from https://money.usnews.com/investing/articles/2017-06-23/should-i-buy-johnson-johnson-stock-jnj